Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
PTEN expression
Description:
PTEN expression is the production of the PTEN tumor-suppressor protein in cells, measured in cancer research and other biomedical contexts.
Related topics:
Colorectal Cancer Treatments and Studies (11%),
PI3K/AKT/mTOR signaling in cancer (8%)
OpenAlex ID:
keywords/pten-expression
Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
2009
·
Pierre Laurent-Puig
, Anne Cayre
, et al.
·
Journal of Clinical Oncology
·
753
Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma
2013
·
Kerstin Trunzer
, Anna C. Pavlick
, et al.
·
Journal of Clinical Oncology
·
399
PDF
Hyaluronan Oligosaccharides Inhibit Anchorage-independent Growth of Tumor Cells by Suppressing the Phosphoinositide 3-Kinase/Akt Cell Survival Pathway
2002
·
Shibnath Ghatak
, Suniti Misra
, et al.
·
Journal of Biological Chemistry
·
354
PDF
Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer
2016
·
Zhou Du
, Tong Sun
, et al.
·
Nature Communications
·
336
PDF
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
2008
·
Joshua Z Press
, Alessandro De Luca
, et al.
·
BMC Cancer
·
312
PDF
Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer
2009
·
Andrea Sartore-Bianchi
, Federica Di Nicolantonio
, et al.
·
PLoS ONE
·
280
PDF
PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer
2011
·
Ana M. Gonzalez-Angulo
, Jaime Ferrer-Lozano
, et al.
·
Molecular Cancer Therapeutics
·
242
Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer
2016
·
José Baselga
, Gail D. Lewis Phillips
, et al.
·
Clinical Cancer Research
·
238
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
2011
·
Kenneth J O'Byrne
, Ulrich Gatzemeier
, et al.
·
The Lancet Oncology
·
222
PTEN Mutational Spectra, Expression Levels, and Subcellular Localization in Microsatellite Stable and Unstable Colorectal Cancers
2002
·
Xiao-Ping Zhou
, Anu Loukola
, et al.
·
American Journal Of Pathology
·
202
Management and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institution
2013
·
Pei Yang
, Yongzhi Wang
, et al.
·
Journal of Neuro-Oncology
·
198
PIK3CA, BRAF, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17
2013
·
Christos S. Karapetis
, Derek Jonker
, et al.
·
Clinical Cancer Research
·
181
The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
2013
·
V Eklöf
, M L Wikberg
, et al.
·
British Journal of Cancer
·
181
PDF
PTEN mutations are common in sporadic microsatellite stable colorectal cancer
2004
·
Najah T Nassif
, Glenn P Lobo
, et al.
·
Oncogene
·
166
Focus on PTEN regulation
2015
·
Miriam Bermúdez Brito
, Evangelia Goulielmaki
, et al.
·
Frontiers in Oncology
·
162
PDF
Tumour heterogeneity poses a significant challenge to cancer biomarker research
2017
·
Karolina Cyll
, Elin Ersvær
, et al.
·
British Journal of Cancer
·
156
PDF
PTEN mutation, methylation and expression in breast cancer patients
2013
·
HONG-YAN ZHANG
, FENG LIANG
, et al.
·
Oncology Letters
·
142
PDF
Omega‐3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF‐7 breast cancer cells
2012
·
Daniela Rovito
, Cinzia Giordano
, et al.
·
Journal of Cellular Physiology
·
136
Increased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and Rosiglitazone
2006
·
Rosemary E. Teresi
, Chung‐Wai Shaiu
, et al.
·
International Journal of Cancer
·
130
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study
2010
·
M. Moehler
, A. Mueller
, et al.
·
Annals of Oncology
·
127
PDF
The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic Cholangiocarcinoma
2009
·
Joon-Yong Chung
, Seung-Mo Hong
, et al.
·
Clinical Cancer Research
·
123
PDF
Concordant analysis of KRAS, BRAF, PIK3CA mutations and PTEN expression between primary colorectal cancer and matched metastases
2015
·
Chen Mao
, Xin-Yin Wu
, et al.
·
Scientific Reports
·
119
PDF
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
2020
·
Jarle Bruun
, Kushtrim Kryeziu
, et al.
·
Clinical Cancer Research
·
117
Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells
2010
·
Katri Köninki
, Mark Barok
, et al.
·
Cancer Letters
·
116
PI3K/AKT pathway activation in bladder carcinogenesis
2013
·
Julien Calderaro
, Sandra Rebouissou
, et al.
·
International Journal of Cancer
·
112
Show more works
View as search
Works count:
472
Citation count:
9,914
Year
Topic
Type